The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Developers have a growing array of options for AI-powered low-code and no-code development tools. But using them to their ...

To achieve this AI competitive advantage, many companies are continuing to invest substantially in AI technologies. Over the ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

An evolutionary architecture strategy ensures rapid responses to unforeseen events. Autonomously acting teams make informed ...

The conversation around affordable housing in the United States has shifted in recent years. Rising home prices, limited inventory, and changing migration patterns have pushed cities and developers to ...

In recent months, I’ve noticed a troubling trend with AI coding assistants. After two years of steady improvements, over the ...

Modern leadership demands more than financial performance — it requires a commitment to sustainability and social ...

Statewide paid family and medical leave (PFML) programs deliver essential benefits to individuals who need time away from ...

What happens when intelligence moves off the cloud and onto the device? Edge AI Studio cuts latency, improves performance, ...

The U.S. Naval Research Laboratory (NRL) launched a remote sensing experiment to sharpen artificial intelligence (AI) ...

Despite lingering uncertainty across global manufacturing, recent indicators suggest an improvement in Africa's industrial ...